UNII 6OZP39ZG8H

POLYSORBATE 80

Unique Ingredient Identifier 6OZP39ZG8H is listed as a ingredient substance
Unii6OZP39ZG8H
Preferred Substance NamePOLYSORBATE 80
Rn9005-65-6
NcitC80656
Rxcui8560
Unii TypeINGREDIENT SUBSTANCE
RN9005-65-6
NCITC80656
RXCUI8560
MFPolymer substance not supported

Alternate Names

Dosage Forms

UNII 6OZP39ZG8H POLYSORBATE 80 is commonly included in medications in the following forms.

RouteDosage FormPotency
AURICULAR (OTIC)SOLUTION0.2 %
AURICULAR (OTIC)SOLUTION, DROPS2.5 %
AURICULAR (OTIC)SUSPENSION5 %
IM - IVINJECTION NA
INHALATIONAEROSOL0.02 ug
INHALATIONPOWDER0.22 MG
INHALATIONSUSPENSION0.37 mg/2mL
INHALATIONSUSPENSION, FOR INHALATION0.02 %
INTRA-ARTERIALSUSPENSION, INJECTION1.94 mg/1mL
INTRA-ARTICULARINJECTABLE0.04 %
INTRA-ARTICULARINJECTION0.4 %
INTRA-ARTICULARINJECTION, SUSPENSION, EXTENDED RELEASE5 MG
INTRA-ARTICULARINJECTION, SUSTAINED ACTION NA
INTRABURSALINJECTION0.04 %
INTRADERMALINJECTION NA
INTRADERMALINJECTION, SUSTAINED ACTION NA
INTRALESIONALINJECTABLE0.19 %
INTRALESIONALINJECTION0.2 %
INTRALESIONALINJECTION, SUSTAINED ACTION NA
INTRALESIONALSUSPENSION, INJECTION1.94 mg/1mL
INTRALESIONALSUSPENSION, INJECTION0.19 %
INTRAMUSCULARINJECTABLE1 mg
INTRAMUSCULARINJECTABLE0.19 %W/V
INTRAMUSCULARINJECTION12 %
INTRAMUSCULARINJECTION3.8 mg
INTRAMUSCULARINJECTION0.4 MG/1ML
INTRAMUSCULARINJECTION, MICROSPHERES0.1 %
INTRAMUSCULARINJECTION, SUSPENSION0.24 %
INTRAMUSCULARINJECTION, SUSTAINED ACTION NA
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION NA
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.2 %
INTRAMUSCULARSOLUTION, INJECTION5 %W/V
INTRAMUSCULARSUSPENSION0.02 %
INTRAMUSCULARSUSPENSION, INJECTION2.41 MG/1ML
INTRAMUSCULARSUSPENSION, INJECTION0.24 %W/V
INTRASYNOVIALINJECTABLE0.19 %
INTRASYNOVIALINJECTION0.2 %
INTRASYNOVIALINJECTION, SUSTAINED ACTION NA
INTRASYNOVIALSUSPENSION, INJECTION0.19 %
INTRA-SYNOVIALSUSPENSION, INJECTION9.7 mg
INTRAVENOUSINFUSION NA
INTRAVENOUSINJECTABLE63 %
INTRAVENOUSINJECTION260 mg/1mL
INTRAVENOUSINJECTION10 %
INTRAVENOUSINJECTION, SOLUTION26 %W/V
INTRAVENOUSINJECTION, SUSPENSION0.5 %
INTRAVENOUSLIQUID400 MG/5ML
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED12 %
INTRAVENOUSSOLUTION, INJECTION52 %
INTRAVENOUSSOLUTION, LIQUID100 ug/1mL
INTRAVENOUS INFUSIONINJECTION260 mg/1mL
INTRAVITREALSUSPENSION, INJECTION0.015 %
IV(INFUSION)INJECTABLE52 %
IV(INFUSION)INJECTION260 mg/1mL
IV(INFUSION)INJECTION54 %
IV(INFUSION)INJECTION, SOLUTION54 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION5.3 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED12.5 %
IV(INFUSION)SOLUTION10 %
IV(INFUSION)SOLUTION, CONCENTRATE26 %W/V
IV(INFUSION)SOLUTION, INJECTION58.5 %
NASALSPRAY106 UG/1SPRAY
NASALSPRAY0.5 %
NASALSPRAY, METERED10 %
NASALSUSPENSION NA
OPHTHALMICDROPS0.1 %
OPHTHALMICEMULSION4 %
OPHTHALMICSOLUTION2.5 MG/1ML
OPHTHALMICSOLUTION0.2 %
OPHTHALMICSOLUTION, DROPS1 %
OPHTHALMICSOLUTION, GEL FORMING, EXTENDED RELEASE0.05 %
OPHTHALMICSUSPENSION0.1 %
OPHTHALMICSUSPENSION, DROPS0.1 %
ORALCAPSULE418.37 MG
ORALCAPSULE, COATED PELLETS0.053 MG
ORALCAPSULE, DELAYED ACTION3.05 MG
ORALCAPSULE, DELAYED RELEASE3.82 MG
ORALCAPSULE, ENTERIC COATED PELLETS2 MG
ORALCAPSULE, EXTENDED RELEASE1.56 MG
ORALCAPSULE, HARD GELATIN NA
ORALCAPSULE, SOFT GELATIN80.56 MG
ORALCAPSULE, SOFT GELATIN LIQUID-FILLED6 MG
ORALCAPSULE, SUSTAINED ACTION2.6 MG
ORALCONCENTRATE1 MG/1ML
ORALDROPS2 MG/1ML
ORALGRANULE20 MG
ORALGRANULE, FOR ORAL SUSPENSION5 MG
ORALLIQUID NA
ORALPELLET1.1 MG
ORALPOWDER66 MG/1PKT
ORALPOWDER, FOR ORAL SUSPENSION5 MG/5ML
ORALPOWDER, FOR SOLUTION NA
ORALPOWDER, FOR SUSPENSION5 MG/5ML
ORALSOLUTION126 MG/1ML
ORALSOLUTION, ELIXIR2.5 MG/15ML
ORALSUSPENSION125 MG/5ML
ORALSUSPENSION15 mg/1mL
ORALSUSPENSION1.25 mg/1.25mL
ORALSUSPENSION, DROPS7.5 MG/2.5ML
ORALSUSPENSION, EXTENDED RELEASE10 MG/5ML
ORALSUSPENSION, FOR INHALATION0.4 MG/2 ML
ORALSUSPENSION, LIQUID5 MG/5ML
ORALSUSPENSION, SUSTAINED ACTION5 MG
ORALSUSPENSION, SYRUP, SUSTAINED ACTION0.06 %
ORALTABLET21.25 MG
ORALTABLET (IMMED./COMP. RELEASE), COATED0.5 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED24 MG
ORALTABLET, COATED2.2 MG
ORALTABLET, CONTROLLED RELEASE1.635 mg
ORALTABLET, DELAYED ACTION1.15 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED0.17 MG
ORALTABLET, DELAYED RELEASE0.62 MG
ORALTABLET, EXTENDED RELEASE8 MG
ORALTABLET, FILM COATED14.8 MG
ORALTABLET, FILM COATED, EXTENDED RELEASE0.12 MG
ORALTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE5.68 mg
ORALTABLET, SUSTAINED ACTION0.12 MG
ORALTABLET, SUSTAINED ACTION, COATED8 MG
ORALTABLET, SUSTAINED ACTION, FILM COATED0.2 MG
RECTALENEMA0.35 %
RECTALLIQUID NA
RECTALPOWDER, FOR SOLUTION NA
RECTALSOLUTION0.75 %
RECTALSUPPOSITORY72.15 MG
RESPIRATORY (INHALATION)SUSPENSION, FOR INHALATION0.04 %
SOFT TISSUEINJECTABLE0.04 %
SOFT TISSUEINJECTION0.2 %
SOFT TISSUEINJECTION, SUSTAINED ACTION NA
SOFT TISSUESUSPENSION, INJECTION1.94 mg/1mL
SOFT TISSUESUSPENSION, INJECTION0.19 %
SUBCUTANEOUSINJECTION NA
SUBCUTANEOUSSUSPENSION, INJECTION0.46 %
SUBLINGUALTABLET0.075 MG
TOPICALCREAM, AUGMENTED15 %W/W
TOPICALCREAM, EMULSION, SUSTAINED RELEASE5 %W/W
TOPICALDROPS NA
TOPICALEMULSION2.5 %W/W
TOPICALEMULSION, AEROSOL FOAM0.98 %W/W
TOPICALEMULSION, CREAM4.5 %W/W
TOPICALGEL8.5 %W/W
TOPICALLOTION2.5 %W/W
TOPICALOINTMENT0.1 %W/W
TOPICALPATCH, CONTROLLED RELEASE NA
TOPICALSOLUTION2.5 MG/1ML
VAGINALCREAM0.001 %W/W
VAGINALEMULSION, CREAM0.4 %
VAGINALSUPPOSITORY28 MG

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.